Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism PB2 inhibitors(polymerase basic protein 2 (PB2) inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H18F2N6O2 |
InChIKeyFWEPEQCPHBWQRU-UHFFFAOYSA-N |
CAS Registry1422051-33-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza, Human | Preclinical | CN | 01 Mar 2023 |